{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T10:08:46Z","timestamp":1768644526091,"version":"3.49.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12010-021-03523-x","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T22:02:41Z","timestamp":1625695361000},"page":"2634-2648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Huntington\u2019s Chorea\u2014a Rare Neurodegenerative Autosomal Dominant Disease: Insight into Molecular Genetics, Prognosis and Diagnosis"],"prefix":"10.1007","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2630-2392","authenticated-orcid":false,"given":"Pratik","family":"Talukder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annapurna","family":"Jana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrirupa","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saikat","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"issue":"12","key":"3523_CR1","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan, J. S., Kazantsev, A., Spasic-Boskovic, O., Greenwald, M., Zhu, Y. Z., Gohler, H., & Thompson, L. M. (2000). The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proceedings of the National Academy of Sciences, 97(12), 6763\u20136768. https:\/\/doi.org\/10.1073\/pnas.100110097.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"3523_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","volume":"47","author":"BI Bae","year":"2005","unstructured":"Bae, B. I., Xu, H., Igarashi, S., Fujimuro, M., Agrawal, N., Taya, Y., et al. (2005). p53 mediates cellular dysfunction and behavioral abnormalities in Huntington\u2019s disease. Neuron, 47(1), 29\u201341. https:\/\/doi.org\/10.1016\/j.neuron.2005.06.005.","journal-title":"Neuron"},{"issue":"8","key":"3523_CR3","doi-asserted-by":"publisher","first-page":"e23837","DOI":"10.1371\/journal.pone.0023837","volume":"6","author":"J Ghose","year":"2011","unstructured":"Ghose, J., Sinha, M., Das, E., Jana, N. R., & Bhattacharyya, N. P. (2011). Regulation of miR-146a by RelA\/NFkB and p53 in STHdhQ111\/HdhQ111 cells, a cell model of Huntington\u2019s disease. PloS ONE, 6(8), e23837. https:\/\/doi.org\/10.1371\/journal.pone.0023837.","journal-title":"PloS ONE"},{"issue":"6500","key":"3523_CR4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/371762a0","volume":"371","author":"A Pause","year":"1994","unstructured":"Pause, A., Belsham, G. J., Gingras, A. C., Donz\u00e9, O., Lin, T. A., Lawrence, J. C., & Sonenberg, N. (1994). Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function. Nature, 371(6500), 762\u2013767. https:\/\/doi.org\/10.1038\/371762a0.","journal-title":"Nature"},{"issue":"11","key":"3523_CR5","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1101\/gad.13.11.1422","volume":"13","author":"AC Gingras","year":"1999","unstructured":"Gingras, A. C., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R., & Sonenberg, N. (1999). Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes & development, 13(11), 1422\u20131437.","journal-title":"Genes & development"},{"issue":"1","key":"3523_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12885-016-2418-7","volume":"16","author":"H Ito","year":"2016","unstructured":"Ito, H., Ichiyanagi, O., Naito, S., Bilim, V. N., Tomita, Y., Kato, T., Nagaoka, A., & Tsuchiya, N. (2016). GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition. BMC cancer, 16(1), 393. https:\/\/doi.org\/10.1186\/s12885-016-2418-7.","journal-title":"BMC cancer"},{"issue":"3","key":"3523_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","volume":"20","author":"SH Li","year":"2004","unstructured":"Li, S. H., & Li, X. J. (2004). Huntingtin\u2013protein interactions and the pathogenesis of Huntington's disease. TRENDS in Genetics, 20(3), 146\u2013154. https:\/\/doi.org\/10.1016\/j.tig.2004.01.008.","journal-title":"TRENDS in Genetics"},{"issue":"2","key":"3523_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/hmg\/ddm301","volume":"17","author":"S Raychaudhuri","year":"2008","unstructured":"Raychaudhuri, S., Sinha, M., Mukhopadhyay, D., & Bhattacharyya, N. P. (2008). HYPK, a Huntingtin interacting protein, reduces aggregates and apoptosis induced by N-terminal Huntingtin with 40 glutamines in Neuro2a cells and exhibits chaperone-like activity. Human molecular genetics, 17(2), 240\u2013255. https:\/\/doi.org\/10.1093\/hmg\/ddm301.","journal-title":"Human molecular genetics"},{"issue":"5","key":"3523_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JPG Vonsattel","year":"1998","unstructured":"Vonsattel, J. P. G., & DiFiglia, M. (1998). Huntington disease. Journal of neuropathology and experimental neurology, 57(5), 369\u2013384.","journal-title":"Journal of neuropathology and experimental neurology"},{"issue":"2","key":"3523_CR10","first-page":"343","volume":"57","author":"B Kremer","year":"1995","unstructured":"Kremer, B., Almqvist, E., Theilmann, J., Spence, N., Telenius, H., Goldberg, Y. P., & Hayden, M. R. (1995). Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes. American journal of human genetics, 57(2), 343.","journal-title":"American journal of human genetics"},{"issue":"12","key":"3523_CR11","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1093\/hmg\/3.12.2103","volume":"3","author":"F Squitieri","year":"1994","unstructured":"Squitieri, F., Andrew, S. E., Goldberg, Y. P., Kremer, B., Spence, N., Zelsler, J., et al. (1994). DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence. Human molecular genetics, 3(12), 2103\u20132114. https:\/\/doi.org\/10.1093\/hmg\/3.12.2103.","journal-title":"Human molecular genetics"},{"issue":"10","key":"3523_CR12","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/hmg\/2.10.1713","volume":"2","author":"DC Rubinsztein","year":"1993","unstructured":"Rubinsztein, D. C., Barton, D. E., Davison, B. C., & Ferguson-Smith, M. A. (1993). Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington\u2019s disease and CAG repeat number. Human molecular genetics, 2(10), 1713\u20131715. https:\/\/doi.org\/10.1093\/hmg\/2.10.1713.","journal-title":"Human molecular genetics"},{"issue":"1-2","key":"3523_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jns.2010.08.024","volume":"298","author":"M Ma","year":"2010","unstructured":"Ma, M., Yang, Y., Shang, H., Su, D., Zhang, H., Ma, Y., Liu, Y., Tao, D., & Zhang, S. (2010). Evidence for a predisposing background for CAG expansion leading to HTT mutation in a Chinese population. Journal of the neurological sciences, 298(1-2), 57\u201360. https:\/\/doi.org\/10.1016\/j.jns.2010.08.024.","journal-title":"Journal of the neurological sciences"},{"issue":"2","key":"3523_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000079938","volume":"52","author":"CK Wang","year":"2004","unstructured":"Wang, C. K., Wu, Y. R., Hwu, W. L., Chen, C. M., Ro, L. S., Chen, S. T., et al. (2004). DNA haplotype analysis of CAG repeat in Taiwanese Huntington\u2019s disease patients. European neurology, 52(2), 96\u2013100. https:\/\/doi.org\/10.1159\/000079938.","journal-title":"European neurology"},{"issue":"4","key":"3523_CR15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/BF03401575","volume":"1","author":"F Persichetti","year":"1995","unstructured":"Persichetti, F., Ambrose, C. M., Ge, P., McNeil, S. M., Srinidhi, J., Anderson, M. A., et al. (1995). Normal and expanded Huntington\u2019s disease gene alleles produce distinguishable proteins due to translation across the CAG repeat. Molecular Medicine, 1(4), 374\u2013383. https:\/\/doi.org\/10.1007\/BF03401575.","journal-title":"Molecular Medicine"},{"key":"3523_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuro.2017.01.005","volume":"61","author":"TK Chao","year":"2017","unstructured":"Chao, T. K., Hu, J., & Pringsheim, T. (2017). Risk factors for the onset and progression of Huntington disease. Neurotoxicology, 61, 79\u201399. https:\/\/doi.org\/10.1016\/j.neuro.2017.01.005.","journal-title":"Neurotoxicology"},{"issue":"4","key":"3523_CR17","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1016\/j.ejmg.2011.04.002","volume":"54","author":"NA Aziz","year":"2011","unstructured":"Aziz, N. A., van Belzen, M. J., Coops, I. D., Belfroid, R. D., & Roos, R. A. (2011). Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington\u2019s disease. European journal of medical genetics, 54(4), e413\u2013e418. https:\/\/doi.org\/10.1016\/j.ejmg.2011.04.002.","journal-title":"European journal of medical genetics"},{"issue":"20","key":"3523_CR18","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","volume":"330","author":"B Kremer","year":"1994","unstructured":"Kremer, B., Goldberg, P., Andrew, S. E., Theilmann, J., Telenius, H., Zeisler, J., et al. (1994). A worldwide study of the Huntington\u2019s disease mutation: the sensitivity and specificity of measuring CAG repeats. New England Journal of Medicine, 330(20), 1401\u20131406.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"3523_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/hmg\/3.1.93","volume":"3","author":"A Novelletto","year":"1994","unstructured":"Novelletto, A., Persichetti, F., Sabbadin, G., Mandich, P., Bellone, E., Ajmar, F., Pergola, M., Senno, L. D., E.MacDonald, M., F.Gusella, J., & Frontall, M. (1994). Analysis of the trinucleotide repeat expansion in Italian families affected with Huntington disease. Human molecular genetics, 3(1), 93\u201398. https:\/\/doi.org\/10.1093\/hmg\/3.1.93.","journal-title":"Human molecular genetics"},{"issue":"5","key":"3523_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/jmg.31.5.377","volume":"31","author":"Y Trottier","year":"1994","unstructured":"Trottier, Y., Biancalana, V., & Mandel, J. L. (1994). Instability of CAG repeats in Huntington\u2019s disease: relation to parental transmission and age of onset. Journal of medical genetics, 31(5), 377\u2013382. https:\/\/doi.org\/10.1136\/jmg.31.5.377.","journal-title":"Journal of medical genetics"},{"issue":"3","key":"3523_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1399-0004.1995.tb03941.x","volume":"47","author":"A N\u00f8rrem\u00f8lle","year":"1995","unstructured":"N\u00f8rrem\u00f8lle, A., S\u00f8rensen, S. A., Fenger, K., & Hasholt, L. (1995). Correlation between magnitude of CAG repeat length alterations and length of the paternal repeat in paternally inherited Huntington\u2019s disease. Clinical genetics, 47(3), 113\u2013117. https:\/\/doi.org\/10.1111\/j.1399-0004.1995.tb03941.x.","journal-title":"Clinical genetics"},{"issue":"4","key":"3523_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00005792-200207000-00001","volume":"81","author":"A Maat-Kievit","year":"2002","unstructured":"Maat-Kievit, A., Losekoot, M., Zwinderman, K., Vegter-van der Vlis, M., Belfroid, R., Lopez, F., & Roos, R. (2002). Predictability of age at onset in Huntington disease in the Dutch population. Medicine, 81(4), 251\u2013259.","journal-title":"Medicine"},{"issue":"1","key":"3523_CR23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/ajmg.b.30970","volume":"153","author":"A Semaka","year":"2010","unstructured":"Semaka, A., Collins, J. A., & Hayden, M. R. (2010). Unstable familial transmissions of Huntington disease alleles with 27\u201335 CAG repeats (intermediate alleles). American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153(1), 314\u2013320. https:\/\/doi.org\/10.1002\/ajmg.b.30970.","journal-title":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics"},{"issue":"3","key":"3523_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/humu.9055","volume":"20","author":"S He\u0107imovi\u0107","year":"2002","unstructured":"He\u0107imovi\u0107, S., Klepac, N., Vla\u0161i\u0107, J., Vojta, A., Janko, D., \u0160karpa-Prpi\u0107, I., et al. (2002). Genetic background of huntington disease in Croatia: molecular analysis of CAG, CCG, and \u03942642 (E2642del) polymorphisms. Human mutation, 20(3), 233\u2013233. https:\/\/doi.org\/10.1002\/humu.9055.","journal-title":"Human mutation"},{"issue":"3","key":"3523_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10038-005-0343-8","volume":"51","author":"do Carmo Costa, M., Magalhaes, P., Gui","year":"2006","unstructured":"do Carmo Costa, M., Magalhaes, P., Guimaraes, L., Maciel, P., Sequeiros, J., & Sousa, A. (2006). The CAG repeat at the Huntington disease gene in the Portuguese population: insights into its dynamics and to the origin of the mutation. Journal of human genetics, 51(3), 189\u2013195. https:\/\/doi.org\/10.1007\/s10038-005-0343-8.","journal-title":"Journal of human genetics"},{"issue":"5","key":"3523_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/humu.20167","volume":"25","author":"J Garc\u00eda-Planells","year":"2005","unstructured":"Garc\u00eda-Planells, J., Burguera, J. A., Sol\u00eds, P., Mill\u00e1n, J. M., Ginestar, D., Palau, F., & Espin\u00f3s, C. (2005). Ancient origin of the CAG expansion causing Huntington disease in a Spanish population. Human mutation, 25(5), 453\u2013459. https:\/\/doi.org\/10.1002\/humu.20167.","journal-title":"Human mutation"},{"issue":"4","key":"3523_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000472303","volume":"3","author":"C Yapijakis","year":"1995","unstructured":"Yapijakis, C., Vassilopoulos, D., Tzagournisakis, M., Maris, T., Fesdjian, C., Papageorgiou, C., & Plaitakis, A. (1995). Linkage disequilibrium between the expanded (CAG) n repeat and an allele of the adjacent (CCG) n repeat in Huntington\u2019s disease patients of Greek origin. European Journal of Human Genetics, 3(4), 228\u2013234. https:\/\/doi.org\/10.1159\/000472303.","journal-title":"European Journal of Human Genetics"},{"issue":"1","key":"3523_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/hmg\/3.1.173","volume":"3","author":"LH Barron","year":"1994","unstructured":"Barron, L. H., Rae, A., Holloway, S., Brock, H., & D. J., & Warner, J. P. (1994). A single allele from the polymorphic CCG rich sequence immediately 3'to the unstable CAG trinucleotide in the IT15 cDNA shows almost complete disequilibrium with Huntington's disease chromosomes in the Scottish population. Human molecular genetics, 3(1), 173\u2013175. https:\/\/doi.org\/10.1093\/hmg\/3.1.173.","journal-title":"Human molecular genetics"},{"issue":"3","key":"3523_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1600-0404.1999.tb00738.x","volume":"100","author":"FB Atac","year":"1999","unstructured":"Atac, F. B., Elibol, B., & Schaefer, F. (1999). The genetic analysis of Turkish patients with Huntington's disease. Acta neurologica scandinavica, 100(3), 195\u2013198. https:\/\/doi.org\/10.1111\/j.1600-0404.1999.tb00738.x.","journal-title":"Acta neurologica scandinavica"},{"issue":"8","key":"3523_CR30","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","volume":"48","author":"RH Myers","year":"1991","unstructured":"Myers, R. H., Sax, D. S., Koroshetz, W. J., Mastromauro, C., Cupples, L. A., Kiely, D. K., Pettengill, F. K., & Bird, E. D. (1991). Factors associated with slow progression in Huntington\u2019s disease. Archives of neurology, 48(8), 800\u2013804. https:\/\/doi.org\/10.1001\/archneur.1991.00530200036015.","journal-title":"Archives of neurology"},{"issue":"2","key":"3523_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/mds.870100213","volume":"10","author":"A Feigin","year":"1995","unstructured":"Feigin, A., Kieburtz, K., Bordwell, K., Como, P., Steinberg, K., Sotack, J., Zimmerman, C., Hickey, C., Orme, C., & Shoulson, I. (1995). Functional decline in Huntington\u2019s disease. Movement disorders: official journal of the Movement Disorder Society, 10(2), 211\u2013214.","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"2","key":"3523_CR32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1212\/WNL.54.2.452","volume":"54","author":"K Marder","year":"2000","unstructured":"Marder, K., Zhao, H., Myers, R. H., Cudkowicz, M., Kayson, E., Kieburtz, K., Orme, C., Paulsen, J., Penney, J. B., Siemers, E., & Shoulson, I. (2000). Rate of functional decline in Huntington\u2019s disease. Neurology, 54(2), 452\u2013458. https:\/\/doi.org\/10.1212\/WNL.54.2.452.","journal-title":"Neurology"},{"issue":"3","key":"3523_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.psym.2011.12.010","volume":"53","author":"W Reedeker","year":"2012","unstructured":"Reedeker, W., van der Mast, R. C., Giltay, E. J., Kooistra, T. A. D., Roos, R. A. C., & van Duijn, E. (2012). Psychiatric disorders in Huntington's disease: a 2-year follow-up study. Psychosomatics, 53(3), 220\u2013229. https:\/\/doi.org\/10.1016\/j.psym.2011.12.010.","journal-title":"Psychosomatics"},{"issue":"2-3","key":"3523_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.drugalcdep.2006.06.009","volume":"86","author":"JC Ehret","year":"2007","unstructured":"Ehret, J. C., Day, P. S., Wiegand, R., Wojcieszek, J., & Chambers, R. A. (2007). Huntington disease as a dual diagnosis disorder: data from the National Research Roster for Huntington disease patients and families. Drug and alcohol dependence, 86(2-3), 283\u2013286. https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.06.009.","journal-title":"Drug and alcohol dependence"},{"issue":"2-3","key":"3523_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0022-510X(87)90164-X","volume":"80","author":"OJS Buruma","year":"1987","unstructured":"Buruma, O. J. S., Van der Kamp, W., Barendswaard, E. C., Roos, R. A. C., Kromhout, D., & Van der Velde, E. A. (1987). Which factors influence age at onset and rate of progression in Huntington\u2019s disease? Journal of the neurological sciences, 80(2-3), 299\u2013306. https:\/\/doi.org\/10.1016\/0022-510X(87)90164-X.","journal-title":"Journal of the neurological sciences"},{"key":"3523_CR36","first-page":"104","volume":"71","author":"D Zielonka","year":"2008","unstructured":"Zielonka, D., Niezgoda, A., Olejniczak, M., Krzyzosiak, W., Marcinkowski, J., & Kozubski, W. (2008). Gender differences in the CAG repeats and clinical picture correlations in Huntington\u2019s disease. Ceska a Slovenska Neurologie a Neurochirurgie, 71, 104.","journal-title":"Ceska a Slovenska Neurologie a Neurochirurgie"},{"issue":"2","key":"3523_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/mds.22907","volume":"25","author":"P Auinger","year":"2010","unstructured":"Auinger, P., Kieburtz, K., & Mcdermott, M. P. (2010). The relationship between uric acid levels and Huntington\u2019s disease progression. Movement disorders, 25(2), 224\u2013228. https:\/\/doi.org\/10.1002\/mds.22907.","journal-title":"Movement disorders"},{"issue":"3","key":"3523_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1469-1809.2006.00335.x","volume":"71","author":"JM Andresen","year":"2007","unstructured":"Andresen, J. M., Gay\u00e1n, J., Djouss\u00e9, L., Roberts, S., Brocklebank, D., Cherny, S. S., et al. (2007). The relationship between CAG repeat length and age of onset differs for Huntington\u2019s disease patients with juvenile onset or adult onset. Annals of human genetics, 71(3), 295\u2013301. https:\/\/doi.org\/10.1111\/j.1469-1809.2006.00335.x.","journal-title":"Annals of human genetics"},{"issue":"7679","key":"3523_CR39","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(70)92119-7","volume":"296","author":"A Barbeau","year":"1970","unstructured":"Barbeau, A. (1970). Parental ascent in the juvenile form of Huntington's chorea. The Lancet, 296(7679), 937. https:\/\/doi.org\/10.1016\/S0140-6736(70)92119-7.","journal-title":"The Lancet"},{"key":"3523_CR40","first-page":"645","volume":"1","author":"AD Merritt","year":"1969","unstructured":"Merritt, A. D., Conneally, P. M., Rahman, N. F., & Drew, A. L. (1969). Juvenile Huntington\u2019s chorea. Progress in neurogenetics, 1, 645\u2013650.","journal-title":"Progress in neurogenetics"},{"issue":"5","key":"3523_CR41","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/ana.410070503","volume":"7","author":"CE Finch","year":"1980","unstructured":"Finch, C. E. (1980). The relationships of aging changes in the basal ganglia to manifestations of Huntington\u2019s chorea. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society, 7(5), 406\u2013411. https:\/\/doi.org\/10.1002\/ana.410070503.","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society"},{"issue":"3","key":"3523_CR42","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1399-0004.1974.tb01690.x","volume":"5","author":"CJ Brackenridge","year":"1974","unstructured":"Brackenridge, C. J., & Chamberlin, M. (1974). The relation of the sex of choreic and rigid subjects to the age at onset of Huntington\u2019s disease. Clinical genetics, 5(3), 248\u2013253. https:\/\/doi.org\/10.1111\/j.1399-0004.1974.tb01690.x.","journal-title":"Clinical genetics"},{"issue":"5","key":"3523_CR43","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1600-0404.1979.tb02981.x","volume":"60","author":"CJ Brackenridge","year":"1979","unstructured":"Brackenridge, C. J. (1979). Relation of occupational stress to the age at onset of Huntington\u2019s disease. Acta Neurologica Scandinavica, 60(5), 272\u2013276. https:\/\/doi.org\/10.1111\/j.1600-0404.1979.tb02981.x.","journal-title":"Acta Neurologica Scandinavica"},{"issue":"11","key":"3523_CR44","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/mds.26001","volume":"29","author":"JF Gusella","year":"2014","unstructured":"Gusella, J. F., MacDonald, M. E., & Lee, J. M. (2014). Genetic modifiers of Huntington\u2019s disease. Movement Disorders, Official Journal of the International Parkinson and Movement Disorder Society, 29(11), 1359\u20131365. https:\/\/doi.org\/10.1002\/mds.26001.","journal-title":"Movement Disorders, Official Journal of the International Parkinson and Movement Disorder Society"},{"issue":"2","key":"3523_CR45","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/mds.24024","volume":"27","author":"A Rosenblatt","year":"2012","unstructured":"Rosenblatt, A., Kumar, B. V., Mo, A., Welsh, C. S., Margolis, R. L., & Ross, C. A. (2012). Age, CAG repeat length, and clinical progression in Huntington\u2019s disease. Movement disorders, Official Journal of the International Parkinson and Movement Disorder Society., 27(2), 272\u2013276. https:\/\/doi.org\/10.1002\/mds.24024.","journal-title":"Movement disorders, Official Journal of the International Parkinson and Movement Disorder Society."},{"issue":"3","key":"3523_CR46","first-page":"460","volume":"50","author":"PS Harper","year":"1992","unstructured":"Harper, P. S. (1992). Huntington disease and the abuse of genetics. American journal of human genetics, 50(3), 460\u2013464.","journal-title":"American journal of human genetics"},{"issue":"4","key":"3523_CR47","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/hmg\/ddn404","volume":"18","author":"H Wang","year":"2009","unstructured":"Wang, H., Lim, P. J., Karbowski, M., & Monteiro, M. J. (2009). Effects of overexpression of huntingtin proteins on mitochondrial integrity. Human molecular genetics, 18(4), 737\u2013752. https:\/\/doi.org\/10.1093\/hmg\/ddn404.","journal-title":"Human molecular genetics"},{"issue":"15","key":"3523_CR48","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1111\/j.1742-4658.2007.05922.x","volume":"274","author":"P Majumder","year":"2007","unstructured":"Majumder, P., Choudhury, A., Banerjee, M., Lahiri, A., & Bhattacharyya, N. P. (2007). Interactions of HIPPI, a molecular partner of Huntingtin interacting protein HIP1, with the specific motif present at the putative promoter sequence of the caspase-1, caspase-8 and caspase-10 genes. The FEBS Journal, 274(15), 3886\u20133899. https:\/\/doi.org\/10.1111\/j.1742-4658.2007.05922.x.","journal-title":"The FEBS Journal"},{"issue":"13","key":"3523_CR49","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1038\/sj.embor.7400250","volume":"22","author":"M Metzler","year":"2003","unstructured":"Metzler, M., Li, B., Gan, L., Georgiou, J., Gutekunst, C. A., Wang, Y., et al. (2003). Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor trafficking. The EMBO Journal, 22(13), 3254\u20133266. https:\/\/doi.org\/10.1038\/sj.embor.7400250.","journal-title":"The EMBO Journal"},{"issue":"10","key":"3523_CR50","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/sj.embor.7400250","volume":"5","author":"C Landles","year":"2004","unstructured":"Landles, C., & Bates, G. P. (2004). Huntingtin and the molecular pathogenesis of Huntington\u2019s disease: fourth in molecular medicine review series. EMBO reports, 5(10), 958\u2013963. https:\/\/doi.org\/10.1038\/sj.embor.7400250.","journal-title":"EMBO reports"},{"issue":"6","key":"3523_CR51","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1073\/pnas.1221891110","volume":"110","author":"K Sathasivam","year":"2013","unstructured":"Sathasivam, K., Neueder, A., Gipson, T. A., Landles, C., Benjamin, A. C., Bondulich, M. K., et al. (2013). Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proceedings of the National Academy of Sciences, 110(6), 2366\u20132370. https:\/\/doi.org\/10.1073\/pnas.1221891110.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"3523_CR52","first-page":"161","volume":"2","author":"AM Ardekani","year":"2010","unstructured":"Ardekani, A. M., & Naeini, M. M. (2010). The role of microRNAs in human diseases. Avicenna journal of medical biotechnology, 2(4), 161\u2013179.","journal-title":"Avicenna journal of medical biotechnology"},{"issue":"4","key":"3523_CR53","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12017-012-8183-0","volume":"14","author":"M Sinha","year":"2012","unstructured":"Sinha, M., Mukhopadhyay, S., & Bhattacharyya, N. P. (2012). Mechanism (s) of alteration of micro RNA expressions in Huntington\u2019s disease and their possible contributions to the observed cellular and molecular dysfunctions in the disease. Neuromolecular medicine, 14(4), 221\u2013243. https:\/\/doi.org\/10.1007\/s12017-012-8183-0.","journal-title":"Neuromolecular medicine"},{"issue":"4","key":"3523_CR54","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nprot.2014.051","volume":"9","author":"R Aviner","year":"2014","unstructured":"Aviner, R., Geiger, T., & Elroy-Stein, O. (2014). Genome-wide identification and quantification of protein synthesis in cultured cells and whole tissues by puromycin-associated nascent chain proteomics (PUNCH-P). Nature protocols, 9(4), 751\u2013760. https:\/\/doi.org\/10.1038\/nprot.2014.051.","journal-title":"Nature protocols"},{"issue":"4","key":"3523_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.19080\/GJPPS.2018.06.555693","volume":"6","author":"P Malkani","year":"2018","unstructured":"Malkani, P., Raj, P., & Singh, A. (2018). A clinical review on Huntington disease. Global Journal of Pharmacy & Pharmaceutical Sciences, 6(4), 88\u201392. https:\/\/doi.org\/10.19080\/GJPPS.2018.06.555693.","journal-title":"Global Journal of Pharmacy & Pharmaceutical Sciences"},{"issue":"1","key":"3523_CR56","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross, C. A., & Tabrizi, S. J. (2011). Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. The Lancet Neurology, 10(1), 83\u201398. https:\/\/doi.org\/10.1016\/S1474-4422(10)70245-3.","journal-title":"The Lancet Neurology"},{"issue":"9369","key":"3523_CR57","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","volume":"361","author":"G Bates","year":"2003","unstructured":"Bates, G. (2003). Huntingtin aggregation and toxicity in Huntington\u2019s disease. The Lancet, 361(9369), 1642\u20131644. https:\/\/doi.org\/10.1016\/S0140-6736(03)13304-1.","journal-title":"The Lancet"},{"issue":"12","key":"3523_CR58","doi-asserted-by":"publisher","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","volume":"285","author":"C Landles","year":"2010","unstructured":"Landles, C., Sathasivam, K., Weiss, A., Woodman, B., Moffitt, H., Finkbeiner, S., et al. (2010). Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. Journal of Biological Chemistry, 285(12), 8808\u20138823. https:\/\/doi.org\/10.1074\/jbc.M109.075028.","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"3523_CR59","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/sj.embor.7400250","volume":"5","author":"C Landles","year":"2004","unstructured":"Landles, C., & Bates, G. P. (2004). Huntingtin and the molecular pathogenesis of Huntington\u2019s disease: fourth in molecular medicine review series. EMBO reports, 5(10), 958\u2013963. https:\/\/doi.org\/10.1038\/sj.embor.7400250.","journal-title":"EMBO reports"},{"issue":"9","key":"3523_CR60","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1134\/S0006297918090043","volume":"83","author":"SN Illarioshkin","year":"2018","unstructured":"Illarioshkin, S. N., Klyushnikov, S. A., Vigont, V. A., Seliverstov, Y. A., & Kaznacheyeva, E. V. (2018). Molecular pathogenesis in Huntington\u2019s disease. Biochemistry (Moscow), 83(9), 1030\u20131039. https:\/\/doi.org\/10.1134\/S0006297918090043.","journal-title":"Biochemistry (Moscow)"},{"issue":"43","key":"3523_CR61","doi-asserted-by":"publisher","first-page":"17204","DOI":"10.1073\/pnas.0708285104","volume":"104","author":"M DiFiglia","year":"2007","unstructured":"DiFiglia, M., Sena-Esteves, M., Chase, K., Sapp, E., Pfister, E., Sass, M., et al. (2007). Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proceedings of the National Academy of Sciences, 104(43), 17204\u201317209. https:\/\/doi.org\/10.1073\/pnas.0708285104.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"8","key":"3523_CR62","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bj\u00f6rkqvist","year":"2008","unstructured":"Bj\u00f6rkqvist, M., Wild, E. J., Thiele, J., Silvestroni, A., Andre, R., Lahiri, N., et al. (2008). A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. The Journal of experimental medicine, 205(8), 1869\u20131877.","journal-title":"The Journal of experimental medicine"},{"issue":"10","key":"3523_CR63","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/nn1006-1205","volume":"9","author":"CA Ross","year":"2006","unstructured":"Ross, C. A., & Cleveland, D. W. (2006). Intercellular miscommunication in polyglutamine pathogenesis. Nature neuroscience, 9(10), 1205\u20131206. https:\/\/doi.org\/10.1038\/nn1006-1205.","journal-title":"Nature neuroscience"},{"issue":"2","key":"3523_CR64","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","volume":"90","author":"R Schwarcz","year":"2010","unstructured":"Schwarcz, R., Guidetti, P., Sathyasaikumar, K. V., & Muchowski, P. J. (2010). Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington\u2019s disease. Progress in neurobiology, 90(2), 230\u2013245. https:\/\/doi.org\/10.1016\/j.pneurobio.2009.04.005.","journal-title":"Progress in neurobiology"},{"issue":"5","key":"3523_CR65","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/ng1542","volume":"37","author":"F Giorgini","year":"2005","unstructured":"Giorgini, F., Guidetti, P., Nguyen, Q., Bennett, S. C., & Muchowski, P. J. (2005). A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. Nature genetics, 37(5), 526\u2013531. https:\/\/doi.org\/10.1038\/ng1542.","journal-title":"Nature genetics"},{"issue":"10","key":"3523_CR66","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/jnnp-2012-304636","volume":"84","author":"SJ Evans","year":"2013","unstructured":"Evans, S. J., Douglas, I., Rawlins, M. D., Wexler, N. S., Tabrizi, S. J., & Smeeth, L. (2013). Prevalence of adult Huntington\u2019s disease in the UK based on diagnoses recorded in general practice records. Journal of Neurology, Neurosurgery & Psychiatry, 84(10), 1156\u20131160. https:\/\/doi.org\/10.1136\/jnnp-2012-304636.","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"3523_CR67","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.conb.2015.01.020","volume":"33","author":"JL Plotkin","year":"2015","unstructured":"Plotkin, J. L., & Surmeier, D. J. (2015). Corticostriatal synaptic adaptations in Huntington's disease. Current opinion in neurobiology, 33, 53\u201362. https:\/\/doi.org\/10.1016\/j.conb.2015.01.020.","journal-title":"Current opinion in neurobiology"},{"issue":"12","key":"3523_CR68","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1001\/jamaneurol.2013.4408","volume":"70","author":"ER Dorsey","year":"2013","unstructured":"Dorsey, E. R., Beck, C. A., Darwin, K., Nichols, P., Brocht, A. F., Biglan, K. M., & Shoulson, I. (2013). Natural history of Huntington disease. JAMA neurology, 70(12), 1520\u20131530. https:\/\/doi.org\/10.1001\/jamaneurol.2013.4408.","journal-title":"JAMA neurology"},{"issue":"7","key":"3523_CR69","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","volume":"66","author":"A Rosenblatt","year":"2006","unstructured":"Rosenblatt, A., Liang, K. Y., Zhou, H., Abbott, M. H., Gourley, L. M., Margolis, R. L., et al. (2006). The association of CAG repeat length with clinical progression in Huntington disease. Neurology, 66(7), 1016\u20131020. https:\/\/doi.org\/10.1212\/01.wnl.0000204230.16619.d9.","journal-title":"Neurology"},{"issue":"7","key":"3523_CR70","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi, S. J., Scahill, R. I., Owen, G., Durr, A., Leavitt, B. R., Roos, R. A., et al. (2013). Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data. The Lancet Neurology, 12(7), 637\u2013649. https:\/\/doi.org\/10.1016\/S1474-4422(13)70088-7.","journal-title":"The Lancet Neurology"},{"issue":"3","key":"3523_CR71","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/mds.20332","volume":"20","author":"P Hogarth","year":"2005","unstructured":"Hogarth, P., Kayson, E., Kieburtz, K., Marder, K., Oakes, D., Rosas, D., et al. (2005). Interrater agreement in the assessment of motor manifestations of Huntington\u2019s disease. Movement disorders, 20(3), 293\u2013297. https:\/\/doi.org\/10.1002\/mds.20332.","journal-title":"Movement disorders"},{"issue":"11","key":"3523_CR72","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/mds.26021","volume":"29","author":"C Sampaio","year":"2014","unstructured":"Sampaio, C., Borowsky, B., & Reilmann, R. (2014). Clinical trials in Huntington\u2019s disease: interventions in early clinical development and newer methodological approaches. Movement Disorders, 29(11), 1419\u20131428. https:\/\/doi.org\/10.1002\/mds.26021.","journal-title":"Movement Disorders"},{"issue":"5","key":"3523_CR73","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/mds.25864","volume":"29","author":"M Papoutsi","year":"2014","unstructured":"Papoutsi, M., Labuschagne, I., Tabrizi, S. J., & Stout, J. C. (2014). The cognitive burden in Huntington\u2019s disease: pathology, phenotype, and mechanisms of compensation. Movement Disorders, 29(5), 673\u2013683. https:\/\/doi.org\/10.1002\/mds.25864.","journal-title":"Movement Disorders"},{"issue":"7","key":"3523_CR74","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1136\/jnnp-2011-301940","volume":"83","author":"JC Stout","year":"2012","unstructured":"Stout, J. C., Jones, R., Labuschagne, I., O'Regan, A. M., Say, M. J., Dumas, E. M., et al. (2012). Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease. Journal of Neurology, Neurosurgery & Psychiatry, 83(7), 687\u2013694. https:\/\/doi.org\/10.1136\/jnnp-2011-301940.","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"4","key":"3523_CR75","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., et al. (2014). Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10(4), 204\u2013216. https:\/\/doi.org\/10.1038\/nrneurol.2014.24.","journal-title":"Nature Reviews Neurology"},{"issue":"3","key":"3523_CR76","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","volume":"162","author":"JM Lee","year":"2015","unstructured":"Lee, J. M., Wheeler, V. C., Chao, M. J., Vonsattel, J. P. G., Pinto, R. M., Lucente, D., et al. (2015). Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell, 162(3), 516\u2013526. https:\/\/doi.org\/10.1016\/j.cell.2015.07.003.","journal-title":"Cell"},{"issue":"1","key":"3523_CR77","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan, P., & Tabrizi, S. J. (2018). Huntington\u2019s disease: a clinical review. European journal of neurology, 25(1), 24\u201334. https:\/\/doi.org\/10.1111\/ene.13413.","journal-title":"European journal of neurology"},{"issue":"22","key":"3523_CR78","doi-asserted-by":"publisher","first-page":"9358","DOI":"10.1158\/0008-5472","volume":"68","author":"PA Link","year":"2008","unstructured":"Link, P. A., Baer, M. R., James, S. R., Jones, D. A., & Karpf, A. R. (2008). p53-Inducible ribonucleotide reductase (p53R2\/RRM2B) is a DNA hypomethylation\u2013independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome\/acute myelogenous leukemia. Cancer research, 68(22), 9358\u20139366. https:\/\/doi.org\/10.1158\/0008-5472.","journal-title":"Cancer research"},{"issue":"7","key":"3523_CR79","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1093\/brain\/awz115","volume":"142","author":"M Flower","year":"2019","unstructured":"Flower, M., Lomeikaite, V., Ciosi, M., Cumming, S., Morales, F., Lo, K., et al. (2019). MSH3 modifies somatic instability and disease severity in Huntington\u2019s and myotonic dystrophy type 1. Brain, 142(7), 1876\u20131886. https:\/\/doi.org\/10.1093\/brain\/awz115.","journal-title":"Brain"},{"key":"3523_CR80","unstructured":"Travessa, A., Rodrigues, F., Mestre, T., Sampaio, C., & Ferreira, J. (2016). Fifteen years of clinical trials in Huntington\u2019s disease: too many clinical trial failures: 1135. Movement Disorders, 31."},{"issue":"11","key":"3523_CR81","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1093\/brain\/awn212","volume":"131","author":"V Leoni","year":"2008","unstructured":"Leoni, V., Mariotti, C., Tabrizi, S. J., Valenza, M., Wild, E. J., Henley, S. M., et al. (2008). Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington\u2019s disease. Brain, 131(11), 2851\u20132859. https:\/\/doi.org\/10.1093\/brain\/awn212.","journal-title":"Brain"},{"issue":"41","key":"3523_CR82","doi-asserted-by":"publisher","first-page":"17141","DOI":"10.1073\/pnas.1104409108","volume":"108","author":"Y Hu","year":"2011","unstructured":"Hu, Y., Chopra, V., Chopra, R., Locascio, J. J., Liao, Z., Ding, H., et al. (2011). Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse. Proceedings of the National Academy of Sciences, 108(41), 17141\u201317146. https:\/\/doi.org\/10.1073\/pnas.1104409108.","journal-title":"Proceedings of the National Academy of Sciences"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-021-03523-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-021-03523-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-021-03523-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T06:11:33Z","timestamp":1627625493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-021-03523-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":82,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["3523"],"URL":"https:\/\/doi.org\/10.1007\/s12010-021-03523-x","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]},"assertion":[{"value":"7 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this is a review article, there is no need of any ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable as this is a review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors give the consent for publication.Conflict of Interest\/Competing InterestsThe authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}